Skip to main
NMTC

NMTC Earnings Dates & Reports

NMTC Most Recent Earnings

Report Date
Period EndingQ1 2026
Est. EPS-$0.04
Actual EPS-$0.03
EarningsBeat

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

NMTC Earnings per Share (EPS) History

Signup for full access
Browse free

NMTC Latest Earnings

The value each NMTC share was expected to gain vs. the value each share gained.

NMTC reported its most recent earnings on for Q1 2026, posting earnings per share (EPS) of -$0.03. This exceeded analysts' expectations of -$0.04 by 25.00%, marking a Beat.

For comparison, NeuroOne Medical Technologies Corp reported EPS of $0.06 in the same quarter last year.

The company is expected to announce its next earnings report on , with analysts projecting an EPS of -$0.04.

NMTC Earnings History

Earnings
Est. EPSActual EPSSurprise
Q2 2026
-$0.04
Q1 2026
-$0.04-$0.03-25.00%
Q4 2025
-$0.04-$0.040.00%
Q3 2025
-$0.03
Q2 2025
-$0.07
View all

NMTC Earnings Related Price Changes

Earnings announcements may impact a stock’s price. This table highlights the NeuroOne Medical Technologies Corp’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.

Report datePrice 1D beforePrice 1D afterChange

NMTC Earnings FAQs

NMTC last reported earnings on Feb 11, 2026 for Q1 2026, posting an EPS of -$0.03, which Beat the estimate of -$0.04 by 25.00%.

For Q1 2026, NMTC reported an EPS of -$0.03, exceeding analysts' estimate of -$0.04 by 25.00%.

For Q1 2026, NMTC Beat expectations with an actual EPS of -$0.03 vs. an estimated EPS of -$0.04.

Following the last earnings report on Feb 11, 2026, NMTC's stock price moved — from — to —.

The next NMTC earnings call is scheduled for May. 12, 2026, where executives will discuss financial results and outlook.

NeuroOne Medical Technologies Corp (NMTC)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.